Capital Management Associates Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545K Buy
454
+36
+9% +$36.8K 0.11% 99
2026
Q1
$384K Buy
418
+1
+0.2% +$1.01K 0.09% 109
2025
Q4
$448K Sell
417
-18
-4% -$17.2K 0.1% 99
2025
Q3
$332K Buy
435
+19
+5% +$14.1K 0.09% 104
2025
Q2
$324K Sell
416
-414
-50% -$322K 0.1% 92
2025
Q1
$685K Buy
830
+416
+100% +$346K 0.16% 66
2024
Q4
$320K Sell
414
-1
-0.2% -$828 0.12% 82
2024
Q3
$368K Hold
415
0.15% 74
2024
Q2
$376K Buy
415
+1
+0.2% +$800 0.23% 58
2024
Q1
$322K Hold
414
0.24% 54
2023
Q4
$241K Buy
+414
New +$242K 0.14% 72

Other funds holding LLY

Capital Management Associates Inc's LLY Position: Q2 2026 in Review

Capital Management Associates Inc increased its Eli Lilly (LLY) stake by 8.6% in Q2 2026, buying an estimated $36.8K and bringing the position to 454 shares worth $545K. The position accounts for 0.11% of the portfolio, ranked #99.

Capital Management Associates Inc first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $685K in Q1 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Management Associates Inc held 454 shares of Eli Lilly worth $545K as of Q2 2026.
  • Capital Management Associates Inc bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.11% of Capital Management Associates Inc's portfolio in Q2 2026, its #99 holding.
  • Capital Management Associates Inc first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Capital Management Associates Inc's Eli Lilly position peaked at $685K in Q1 2025.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.